, however he has built up considerable cross-disciplinary knowledge while leading many large and complex engineering projects around the world.
At a manufacturing level they can deliver more reliable quality with lower complexity and cost, while driving operations significantly closer to net-zero….However, on the day we consciously parked any “solution mode” and the morning was spent discussing barriers: -.
see what we see?”.These can broadly be clustered as follows:.The perceived immaturity of the state-of-the-art.
There is a belief that the technology involved in intensified chemistry is not very mature and therefore carries substantial risk.Some of the small-scale hardware has not been fully industrialised, the developing data collection, process and quality control approaches have not been fully tested with regulatory authorities..
Complicated supply chain.
Pharmaceutical manufacturing of a single product through its lifecycle spans multiple functions and sites within each organisation and spans multiple organisations through product acquisitions and contract manufacturing.Intelligent design and automated fabrication remove the need for human ‘interpretation’ of drawings, increasing accuracy and consistency, for greater safety and productivity.
Platform II was designed to use basic materials with the minimum amount of fabrication where possible.Most components use no or low levels of fabrication (these can be thought of as ‘dumb’ components).
These components tend to be the large, heavy, commoditised elements including:.Columns - standard square hollow sections are used with little/no ‘fabrication’ (a single hole is punched or laser cut in each column);.
(Editor: Magnetic Canopies)